PLENVU
Peakpolyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate
NDAORALFOR SOLUTION
Approved
May 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
4
Data completeness
4/8 — Partial
Drug data last refreshed 12h ago · AI intelligence enriched 14h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PLENVU is an oral bowel prep solution containing polyethylene glycol 3350, electrolytes, and ascorbic acid approved in 2018 for colonoscopy preparation. It works as an osmotic laxative that cleanses the colon by drawing water into the intestinal tract. The formulation is designed to be more tolerable than older PEG-based preps while maintaining efficacy.
$8MPart D
PeakStable
6.8 years to LOEEstablished peak-stage product with modest Part D utilization suggesting mature market with limited growth; commercial team likely focused on efficiency and market maintenance.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy
Started Dec 2025
212 enrolled
Bowel Cleansing Prior to Clinical Procedures
A Study to Investigate the Effect of a Meal At 6pm the Day Before the Colonoscopy on the Bowel Cleansing with Plenvu
Started Feb 2023
525 enrolled
Bowel PreparationBowel Preparation for ColonoscopyBowel Cleansing for Colonoscopy+1 more
A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy
Started Oct 2022
400 enrolled
Colon Disease
A Pharmacokinetic Study of PLENVU® in Healthy Subjects
Started Sep 2020
19 enrolled
Pharmacokinetic
Worked on PLENVU at Salix Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.